LONDON, March 12, 2014 /PRNewswire/ --
On Tuesday, March 11, 2014, the NASDAQ Composite finished at 4,307.19, down 0.63%. The Dow Jones Industrial Average closed the session at 16,351.25, down 0.41% and the S&P 500 ended the day at 1867.63, lower by 0.51%. The losses were broad based as nine out of ten sectors ended the session in negative. Investor-Edge.com looks at some of the equities that hit a new 52-week high during the last session. These include Allergan Inc. (NYSE:AGN), Aetna Inc. (NYSE:AET), Ecolab Inc. (NYSE:ECL), and BioDelivery Sciences International Inc. (NASDAQ:BDSI). Free research on these four companies can be accessed at:
http://investor-edge.com/register
Allergan Inc.'s stock fluctuated in the range of $128.06 and $130.00 during Tuesday's session, hitting a new 52-week high of $130.00. The stock reported a loss of 0.54%, closing the day at $128.55. A total of 1.69 million shares were traded, which is below the 3-month average volume of 2.49 million shares. The company's shares have gained 4.76% in the last one month and surged 34.40% in the previous three months. The S&P 500 Health Care Sector Index posted gains of 3.29% in the last one month and 9.92% in the previous three months. Shares of the company were traded at a PE ratio of 28.41 and were up 15.73% on YTD basis. The stock is trading above its 50-day and 200-day moving averages of $119.45 and $99.48, respectively. Sign up and read the free notes on AGN at:
http://www.Investor-Edge.com/03122014/AGN/report.pdf
On Tuesday, Aetna Inc.'s stock closed the day at $73.65, down 0.50%, hitting a new 52-week high of $74.50. The stock recorded a trading volume of 1.69 million shares, compared with the 3-month average volume of 2.60 million shares. Aetna Inc.'s shares traded at a PE ratio of 12.57 and were up 7.38% on YTD basis. Shares of the company have advanced 11.54% in the last one month and 11.09% in the previous three months. The S&P 500 Health Care Sector Index mapped a loss of 0.26% during the session while the same has charted up by 9.92% during the last three months. The stock is trading above its 50-day and 200-day moving averages. Aetna Inc.'s 50-day moving average of $69.62 is above the 200-day moving average of $65.39. Moreover, the company's shares were trading at the Relative Strength Index (RSI) of 69.85. The complimentary notes on AET can be downloaded as in PDF format at:
http://www.Investor-Edge.com/03122014/AET/report.pdf
Ecolab Inc.'s stock edged 0.96% higher, to finish the day at $111.24, hitting a new 52-week high of $111.83. The stock recorded a trading volume of 1.82 million shares, compared with the 3-month average volumes of 1.10 million shares during the Tuesday's session. The company's shares traded at a PE ratio of 32.93 and were up 6.68% on YTD basis. Shares of Ecolab Inc. have advanced 9.69% in the last one month and 7.75% in the previous three months. The S&P 500 Materials Sector Index mapped a loss of 0.98% during the session while the same has advanced 7.92% during the last three months. The stock is trading above its 50-day and 200-day moving averages of $103.43 and $97.86, respectively. Furthermore, the company's shares were trading at the Relative Strength Index (RSI) of 76.61. Register for free on Investor-Edge and access the latest research on ECL at:
http://www.Investor-Edge.com/03122014/ECL/report.pdf
Shares in BioDelivery Sciences Intl. Inc. finished Tuesday's session at $9.45, resulting in a 4.93% loss, after hitting new 52-weeks high of $10.20. A total of 1.41 million shares were traded, as compared to the 3-months average volume of 0.81 million shares. The stock traded between $9.43 and $10.20 during the trading session. The company's shares have advanced 6.66% in the last one month and have witnessed a gain of 92.07% in the previous three months. The BioDelivery Sciences Intl. Inc.'s stocks advanced 60.44% on YTD basis. The S&P 500 Health Care Sector Index mapped a loss of 0.26% during the session while charted up by 3.29% during the last one month. The stock is trading above its 50-day and 200-day moving averages. The company's 200-day moving average of $5.56 is below the 50-day moving average of $7.72. The RSI of BioDelivery Sciences International Inc. stood at 68.35. The complete research on BDSI is available for free at:
http://www.Investor-Edge.com/03122014/BDSI/report.pdf
About Investor-Edge.com
At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
=============
EDITOR NOTES:
=============
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to making mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] Investor-edge.com.
- For any urgent concerns or inquiries, please contact us at compliance [at] Investor-edge.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] Investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
http://www.Investor-Edge.com/
SOURCE Investor-Edge
